Périodique
Treating substance abuse in schizophrenia. An initial report
(Traiter l'abus de substances psychoactives chez des patients schizophrènes. Un rapport préliminaire)
Auteur(s) :
BENNETT, M. E. ;
BELLACK, A. S. ;
GEARON, J. S.
Année :
2001
Page(s) :
163-175
Langue(s) :
Anglais
Refs biblio. :
50
Domaine :
Plusieurs produits / Several products
Thésaurus mots-clés
COMORBIDITE
;
SCHIZOPHRENIE
;
ABUS
;
THERAPIE COMPORTEMENTALE
;
OBSERVANCE DU TRAITEMENT
;
CONSOMMATION
;
EFFICACITE
Note générale :
Journal of Substance Abuse Treatment, 2001, 20, (2), 163-175, tabl.
Résumé :
Schizophrenia patients show alarmingly high rates of substance use disorders. These patients experience neurocognitive and social deficits that make it difficult for them to benefit from effective treatment strategies designed for less-impaired populations. Previously, we described Behavioral Treatment for Substance Abuse in Schizophrenia and discussed how the program was adapted for this population. Here we provide an update of BTSAS, discuss our clinical experience running the intervention, and review how it has changed over five years of development. We present attendance, participation, and substance use data on patients who consented to attend (n = 42), completed (n = 14), and dropped out (n = 14) of the program. Outcome data are provided for 14 patients, and comparisons are made between good (n = 5; > 67% of urine tests clean from a goal drug over 6 months) and poor (n = 9;
Affiliation :
Dept. Psychiat., Univ. Maryland Sch. Med., Adm. Building, 737 West Lombard Street, Baltimore, MD 21201.
Etats-Unis. United States.
Etats-Unis. United States.